Paul Edick is the founder of Xeris Pharmaceuticals. Xeris Pharmaceuticals has raised $200M in total funding. Latest round: IPO.
Paul R. Edick is a highly accomplished pharmaceutical industry executive, currently serving as President and CEO of Xeris Pharmaceuticals. The company is a specialty biopharmaceutical company focused on the development and commercialization of novel formulations of injectable drugs. Prior to Xeris, Edick was CEO of Durata Therapeutics, which he took public and sold. He also served as Chairman and CEO of Ganic Pharmaceuticals Inc. and President and CEO of Medpointe Healthcare Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library